Guangdong Jiaying Pharmaceutical Co., Ltd
SHZ: 002198.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Junping Shi
- Employees
- 700
- Headquarters
- Meizhou, China
- IPO year
- 2007
- Market cap
- CN¥2.5B
- Website
- https://www.gdjyzy.com.cn
Loading 002198…
Loading profile data…Frequently asked questions about 002198
What does Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) do?
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in Mainland China, Taiwan, Hong Kong and Macao, Southeast Asia, Europe, the United States, and internationally. The company provides medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology,...
Where does 002198.SZ trade?
Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002198.SZ in?
Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Guangdong Jiaying Pharmaceutical Co., Ltd?
Junping Shi is the chief executive officer of Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ).
Where is Guangdong Jiaying Pharmaceutical Co., Ltd headquartered?
Guangdong Jiaying Pharmaceutical Co., Ltd is headquartered in China.
Does 002198.SZ pay a dividend?
Yes — Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) paid a trailing twelve-month dividend of CNY 0.05 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002198.SZ go public?
Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) completed its initial public offering in 2007.